Clinical Research Directory
Browse clinical research sites, groups, and studies.
4 clinical studies listed.
Filters:
Tundra lists 4 Nail Psoriasis clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT06578728
Local Methotrexate Injections for the Treatment of Nail Psoriasis
The investigators hope to learn the efficacy of methotrexate injections for treatment of nail psoriasis.
Gender: All
Ages: 18 Years - Any
Updated: 2026-03-25
1 state
NCT07313072
Topical Use of 2% Tofacitinib for Nail Psoriasis: an Exploratory Clinical Study
To evaluate the efficacy and safety of topical 2% tofacitinib nail lacquer in nail psoriasis, using the NAPSI and DLQI scales before and after 26 weeks of treatment.
Gender: All
Ages: 18 Years - Any
Updated: 2026-03-18
NCT07029516
Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis
A randomized, double blind, placebo-controlled, unicenter, parallel group study to assess the efficacy, safety and tolerability of a multi-funtion toe nail patch in patients affected by nail fragility, nail mychosis and psoriasis 72 patients in 6 subgroups Treatment duration 3 months + 1 month follow-up
Gender: All
Ages: 18 Years - Any
Updated: 2026-01-26
NCT06802848
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Xeligekimab Injection was approved in China on August 20, 2024, for treating adults with moderate to severe plaque psoriasis who are candidates for systemic treatment or phototherapy. Despite the promising efficacy and safety shown in the phase III clinical trial, real-world data is needed to further support clinical decisions for this patient group. This study aims to evaluate the effectiveness and safety of xeligekimab in real-world clinical settings for adults with moderate to severe plaque psoriasis.
Gender: All
Ages: 18 Years - Any
Updated: 2025-01-31
1 state